Skip to content
PICO Portalanswers from OpenAlex

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

PaperCitations, authors & open-access status

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is a paper indexed in PICO Portal from OpenAlex.

How many citations does MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers have?

PICO Portalcitation count

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers has 616 citations in the OpenAlex counts PICO Portal stores.

When was MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers published?

PICO Portalyear

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers has 2011 year in the PICO Portal index.

What is the open-access status of MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?

PICO Portaloa status

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers has closed oa status in the PICO Portal index.

What is the DOI of MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?

PICO Portaldoi

The DOI for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is on the source record.

What is the PMID of MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?

PICO Portalpmid

The PMID for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is on the source record.

What is the OpenAlex record for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?

PICO Portalopenalex

The OpenAlex for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial